Related Experiment Video
Updated: Mar 24, 2026

08:57
Quantification of Optic Nerve Cross Sectional Area on MRI: A Novel Protocol using Fiji Software
Published on: September 4, 2021
4.6K
MRI Screening for Optic Gliomas in Neurofibromatosis Type 1
1Division of Neurology, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL; Departments of Pediatrics and Neurology, Northwestern University Feinberg School of Medicine, Chicago, IL.
Pediatric Neurology Briefs
|March 3, 2016
Summary
This study evaluated the usefulness of MRI scans for children with neurofibromatosis type 1 (NF1). It analyzed data from 826 children over 20 years to determine the utility of screening brain and orbital MRIs.
Area of Science:
- Pediatric Neurology
- Medical Imaging
- Genetics
Background:
- Neurofibromatosis type 1 (NF1) is a genetic disorder affecting nerve growth.
- Brain and orbital abnormalities are common in children with NF1.
- Screening MRIs are often used to monitor these potential complications.
Purpose of the Study:
- To retrospectively assess the diagnostic utility of screening brain and orbital Magnetic Resonance Imaging (MRI) in children diagnosed with neurofibromatosis type 1 (NF1).
- To evaluate the yield of these imaging studies in a large pediatric cohort over a significant time span.
Main Methods:
- Retrospective analysis of 826 children (ages 1-9 years) with NF1.
- Data collected over a 20-year period (1990-2010) from Cincinnati Children's Hospital.
- Review of screening brain/orbital MRI reports and associated clinical data.
Main Results:
- The study analyzed the findings from screening brain/orbital MRIs in 826 children with NF1.
- The data spanned a 20-year period, from 1990 to 2010.
- The cohort included 402 females and 424 males aged 1-9 years.
Conclusions:
- The study provides insights into the long-term utility of neuroimaging in pediatric NF1 management.
- Findings contribute to understanding the role of screening MRIs in this population.
- The research highlights the importance of evaluating imaging protocols in chronic genetic conditions.

